# Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)

> **NCT00312858** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 653 (actual)

## Conditions studied

- Hepatitis A Virus

## Interventions

- **BIOLOGICAL:** Comparator: VAQTA™ (Hepatitis A vaccine)
- **BIOLOGICAL:** Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine)
- **BIOLOGICAL:** Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)

## Key facts

- **NCT ID:** NCT00312858
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 653 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00312858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00312858, "Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00312858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*